DE1242239B - Verfahren zur Herstellung von neuen Phosphorsaeureestern und gegebenenfalls deren Salzen - Google Patents
Verfahren zur Herstellung von neuen Phosphorsaeureestern und gegebenenfalls deren SalzenInfo
- Publication number
- DE1242239B DE1242239B DES74712A DES0074712A DE1242239B DE 1242239 B DE1242239 B DE 1242239B DE S74712 A DES74712 A DE S74712A DE S0074712 A DES0074712 A DE S0074712A DE 1242239 B DE1242239 B DE 1242239B
- Authority
- DE
- Germany
- Prior art keywords
- acid
- parts
- salts
- general formula
- acid esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims description 14
- 238000000034 method Methods 0.000 title claims description 7
- 150000003014 phosphoric acid esters Chemical class 0.000 title claims description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 7
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000004508 fractional distillation Methods 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000002430 hydrocarbons Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 claims description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- -1 ester acids Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- RHSDKKXLNNCMIC-UHFFFAOYSA-N 4-[4-(4-hydroxyphenyl)butyl]phenol Chemical compound C1=CC(O)=CC=C1CCCCC1=CC=C(O)C=C1 RHSDKKXLNNCMIC-UHFFFAOYSA-N 0.000 description 1
- AYADRHKBOQJWQG-UHFFFAOYSA-N 4-[6-(4-hydroxyphenyl)hexyl]phenol Chemical compound C1=CC(O)=CC=C1CCCCCCC1=CC=C(O)C=C1 AYADRHKBOQJWQG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- GGISZLOBBISXOZ-UHFFFAOYSA-N acetic acid;chloroform Chemical compound CC(O)=O.ClC(Cl)Cl GGISZLOBBISXOZ-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- HFDWIMBEIXDNQS-UHFFFAOYSA-L copper;diformate Chemical compound [Cu+2].[O-]C=O.[O-]C=O HFDWIMBEIXDNQS-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
- 229940012189 methyl orange Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH787660A CH387060A (de) | 1960-07-09 | 1960-07-09 | Verfahren zur Herstellung von neuen Di-(ortho-phosphorsäure)-monoestern |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1242239B true DE1242239B (de) | 1967-06-15 |
Family
ID=4331736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DES74712A Pending DE1242239B (de) | 1960-07-09 | 1961-07-07 | Verfahren zur Herstellung von neuen Phosphorsaeureestern und gegebenenfalls deren Salzen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3163670A (enExample) |
| CH (1) | CH387060A (enExample) |
| DE (1) | DE1242239B (enExample) |
| ES (1) | ES268847A1 (enExample) |
| GB (1) | GB991018A (enExample) |
| NL (1) | NL266831A (enExample) |
| SE (1) | SE301982B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3492380A (en) * | 1967-03-07 | 1970-01-27 | Pennwalt Corp | Process for encapsulation |
| US3471540A (en) * | 1967-03-22 | 1969-10-07 | Phillips Petroleum Co | Production of metal salts of dihydrocarbyldithiophosphoric acids |
| JPS5093949A (enExample) * | 1973-12-24 | 1975-07-26 | ||
| US4150068A (en) * | 1975-07-24 | 1979-04-17 | Mitsubishi Gas Chemical Company, Inc. | Flame retardant for synthetic resins |
| US4059655A (en) * | 1975-11-24 | 1977-11-22 | Ppg Industries, Inc. | Process for preparing halogenated diaryl hydrogen phosphates |
| US4170614A (en) * | 1977-09-06 | 1979-10-09 | Ppg Industries, Inc. | Process for preparing halogenated diaryl hydrogen phosphates |
| US20030162753A1 (en) * | 1999-01-21 | 2003-08-28 | Peerce Brian E. | Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE702769C (de) * | 1937-10-24 | 1941-02-15 | Buichiro Ayukawa | Verfahren zur Herstellung von Phosphorsaeureestern des Dithymols und Dihalogendithymols |
| US2395934A (en) * | 1939-07-17 | 1946-03-05 | Ciba Pharm Prod Inc | Esters and process of producing same |
| US2490573A (en) * | 1944-12-22 | 1949-12-06 | Hoffmann La Roche | Process for the manufacture of phosphorus compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2234311A (en) * | 1938-09-16 | 1941-03-11 | Ciba Pharm Prod Inc | Esters of hydroxystilbenes and process of preparing same |
| US2826592A (en) * | 1954-01-27 | 1958-03-11 | Shell Dev | Epoxy esters of phosphorus-containing acids and their use in treating textiles |
| US2964552A (en) * | 1956-08-31 | 1960-12-13 | Leo Ab | Adrenocorticotropic action-retarding and anti-enzymatic substances |
-
0
- NL NL266831D patent/NL266831A/xx unknown
-
1960
- 1960-07-09 CH CH787660A patent/CH387060A/de unknown
-
1961
- 1961-06-26 GB GB23079/61A patent/GB991018A/en not_active Expired
- 1961-07-03 US US121386A patent/US3163670A/en not_active Expired - Lifetime
- 1961-07-07 ES ES0268847A patent/ES268847A1/es not_active Expired
- 1961-07-07 DE DES74712A patent/DE1242239B/de active Pending
- 1961-07-10 SE SE7169/61A patent/SE301982B/xx unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE702769C (de) * | 1937-10-24 | 1941-02-15 | Buichiro Ayukawa | Verfahren zur Herstellung von Phosphorsaeureestern des Dithymols und Dihalogendithymols |
| US2395934A (en) * | 1939-07-17 | 1946-03-05 | Ciba Pharm Prod Inc | Esters and process of producing same |
| US2490573A (en) * | 1944-12-22 | 1949-12-06 | Hoffmann La Roche | Process for the manufacture of phosphorus compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| US3163670A (en) | 1964-12-29 |
| CH387060A (de) | 1965-01-31 |
| ES268847A1 (es) | 1962-03-01 |
| SE301982B (enExample) | 1968-07-01 |
| GB991018A (en) | 1965-05-05 |
| NL266831A (enExample) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1418126A1 (de) | Glucofuranoside und Verfahren zu deren Herstellung | |
| DE1242239B (de) | Verfahren zur Herstellung von neuen Phosphorsaeureestern und gegebenenfalls deren Salzen | |
| DE2265169B2 (de) | Vincaminsäureäthylester, Herstellungsverfahren und pharmazeutische Mittel | |
| DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2942050C2 (de) | 2-Amino- oder 2-thio-substituierte 4,5-Diphenyl-oxazol-derivate und Verfahren zu deren Herstellung | |
| DE1593315C (enExample) | ||
| DE1100639B (de) | Verfahren zur Herstellung von basisch substituierten Barbitursaeure-derivaten | |
| AT227720B (de) | Verfahren zur Herstellung von neuen Phosphorsäureestern | |
| DE2010722C3 (de) | Cyclische Acetale der Pregnanreihe, ihre Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE955419C (de) | Verfahren zur Herstellung von kernalkylierten Phloracylophenonen | |
| DE1593315B1 (de) | 9-Isopropyliden-9,10-dihydroanthracen-10-carbonsaeure-ss-diaethylamino-aethylester,deren Salze und Verfahren zu deren Herstellung | |
| DE1807585C3 (de) | 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
| EP0047928A1 (de) | Neue Derivate von Cardenolid-bis-digitoxosiden, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE1618310C3 (enExample) | ||
| DE1182237B (de) | Verfahren zur Herstellung von 10-[4'-Hydroxy-4'-hydroxyalkylpiperidinoalkyl]-phenthiazin-derivaten | |
| DE1543744C3 (de) | 3-Alkylflavanone und Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
| DE2255108C3 (de) | Verfahren zur Herstellung von 3 a-Hydroxy-5 a-steroiden und 3 a-Hydroxy-19-nor-5 a-pregnan-20-on | |
| DE1804392A1 (de) | 9-0-Kalamycinderivate und Verfahren zu ihrer Herstellung | |
| DE1119263B (de) | Verfahren zur Herstellung neuer Sulfonylurethane | |
| DE1793637C2 (de) | Verfahren zur Herstellung von 3-(2-Chloräthoxy>6-cyan-3,5-pregnadienen. Ausscheidung aus: 1593484 | |
| DE1936695C3 (de) | 2-n-PropyI-5-thiazolcarbonsäure, ihre Salze und Ester, Verfahren zu deren Herstellung sowie therapeutische Zusammensetzungen | |
| DE1418126C (de) | Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE1620054C (de) | Verfahren zur Herstellung von Chinolindenvaten sowie diese Ver bindungen enthaltende Arzneimittel Ausscheidung aus 1470047 | |
| DE1145175B (de) | Verfahren zur Gewinnung von Rescidin aus Pflanzen der Rauwolfiaarten und zur Herstellung von dessen Salzen | |
| DE1080114B (de) | Verfahren zur Herstellung von substituierten Cumaronen |